15 May 2024
MS sufferers in Canterbury missing out on new drug
Dozens of multiple sclerosis sufferers in Canterbury are not getting access to an approved new drug Ocrelizumab. Local businessman Bruce Street spoke to Ingrid Hipkiss.
Recent stories from Morning Report
Get the RNZ app
for easy access to all your favourite programmes
